BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 21973045)

  • 1. Chronic kidney disease stage 5 as the prognostic complement of International Staging System for multiple myeloma.
    Hsiao LT; Yang CF; Yang SH; Gau JP; Yu YB; Hong YC; Liu CY; Liu JH; Chen PM; Chiou TJ; Tzeng CH
    Eur J Haematol; 2012 Feb; 88(2):159-66. PubMed ID: 21973045
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Chronic Kidney Disease Epidemiology Collaboration cystatin C (CKD-EPI-CysC) equation has an independent prognostic value for overall survival in newly diagnosed patients with symptomatic multiple myeloma; is it time to change from MDRD to CKD-EPI-CysC equations?
    Terpos E; Christoulas D; Kastritis E; Katodritou E; Pouli A; Michalis E; Papassotiriou I; Dimopoulos MA;
    Eur J Haematol; 2013 Oct; 91(4):347-55. PubMed ID: 23829647
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Prognostic value of the new international staging system in multiple myeloma. Comparison with Durie-Salmon staging system].
    Conté L G; Figueroa M G; Lois V V; Cabrera C ME; León R A; García L H; Rojas R H
    Rev Med Chil; 2008 Jan; 136(1):7-12. PubMed ID: 18483648
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of renal impairment as one specific comorbidity factor in multiple myeloma: multicenter study in 198 consecutive patients.
    Kleber M; Ihorst G; Deschler B; Jakob C; Liebisch P; Koch B; Sezer O; Engelhardt M
    Eur J Haematol; 2009 Dec; 83(6):519-27. PubMed ID: 19614956
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Analysis of the international staging system of multiple myeloma and its comparison with the DS and IFM staging system in 122 Chinese patients].
    Deng SH; Xu Y; Mai YJ; Wang YF; Zhao YZ; Zou DH; Qiu LG
    Zhonghua Xue Ye Xue Za Zhi; 2008 Apr; 29(4):217-21. PubMed ID: 18843972
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Staging multiple myeloma patients with active disease using serum levels of beta2m-free HLA class I heavy chain together with IgM or platelet count.
    Perosa F; Minoia C; Favoino E; Prete M; Dammacco F
    Blood Cells Mol Dis; 2009; 42(1):71-6. PubMed ID: 18996035
    [TBL] [Abstract][Full Text] [Related]  

  • 7. International staging system for multiple myeloma.
    Greipp PR; San Miguel J; Durie BG; Crowley JJ; Barlogie B; Bladé J; Boccadoro M; Child JA; Avet-Loiseau H; Kyle RA; Lahuerta JJ; Ludwig H; Morgan G; Powles R; Shimizu K; Shustik C; Sonneveld P; Tosi P; Turesson I; Westin J
    J Clin Oncol; 2005 May; 23(15):3412-20. PubMed ID: 15809451
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Are eGFR equations better than IDMS-traceable serum creatinine in classifying chronic kidney disease?
    Pottel H; Martens F
    Scand J Clin Lab Invest; 2009; 69(5):550-61. PubMed ID: 19337946
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The practical implications of using standardized estimation equations in calculating the prevalence of chronic kidney disease.
    Quinn MP; Rainey A; Cairns KJ; Marshall AH; Savage G; Kee F; Peter Maxwell A; Reaney E; Fogarty DG
    Nephrol Dial Transplant; 2008 Feb; 23(2):542-8. PubMed ID: 17890743
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Prognostic analysis and assessment on the clinical staging systems of multiple myeloma--a report of 206 cases].
    Tao ZF; Fu WJ; Chen YB; Yuan ZG; Wang DX; Hou J
    Ai Zheng; 2006 Apr; 25(4):461-4. PubMed ID: 16613681
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Longitudinal assessment of estimated glomerular filtration rate in apparently healthy adults: a post hoc analysis from the JUPITER study (justification for the use of statins in prevention: an intervention trial evaluating rosuvastatin).
    Vidt DG; Ridker PM; Monyak JT; Schreiber MJ; Cressman MD
    Clin Ther; 2011 Jun; 33(6):717-25. PubMed ID: 21704236
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiple myeloma in elderly patients: prognostic factors and outcome.
    Anagnostopoulos A; Gika D; Symeonidis A; Zervas K; Pouli A; Repoussis P; Grigoraki V; Anagnostopoulos N; Economopoulos T; Maniatis A; Dimopoulos MA
    Eur J Haematol; 2005 Nov; 75(5):370-5. PubMed ID: 16191085
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic accuracy of various glomerular filtration rates estimating equations in patients with chronic kidney disease and diabetes.
    Li HX; Xu GB; Wang XJ; Zhang XC; Yang JM
    Chin Med J (Engl); 2010 Mar; 123(6):745-51. PubMed ID: 20368098
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence and staging of chronic kidney disease in renal transplant recipients.
    Costa de Oliveira CM; Mota MU; Mota RS; Nóbrega JO; Melo DS; Vieira AS; Fernandes PF; Campos Hde H; Evangelista JB
    Clin Transplant; 2009; 23(5):628-36. PubMed ID: 19563484
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factors affecting survival in advanced chronic kidney disease patients who choose not to receive dialysis.
    Wong CF; McCarthy M; Howse ML; Williams PS
    Ren Fail; 2007; 29(6):653-9. PubMed ID: 17763158
    [TBL] [Abstract][Full Text] [Related]  

  • 16. International prognostic index (IPI)--a critical comparison with five multiple myeloma staging systems in the group of 270 patients treated by conventional chemotherapy.
    Scudla V; Zemanova M; Minarik J; Bacovsky J; Ordeltova M; Indrak K; Budikova M; Dusek L; Farbiakova V
    Neoplasma; 2006; 53(4):277-84. PubMed ID: 16830053
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Classification of chronic kidney disease by estimated glomerular filtration rate.
    Marsik C; Endler G; Gulesserian T; Wagner OF; Sunder-Plassmann G
    Eur J Clin Invest; 2008 Apr; 38(4):253-9. PubMed ID: 18339005
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiple myeloma staging based on the combination of beta-2-microglobulin and albumin: the role of albumin in the model.
    Mihou D; Katodritou E; Zervas K
    Hematology; 2007 Dec; 12(6):527-31. PubMed ID: 17852450
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of chronic kidney disease in orthotopic heart transplant recipients and kidney allograft recipients using the new Chronic Kidney Disease Epidemiology Collaboration formula.
    Malyszko J; Przybylowski P; Malyszko JS; Iaina-Levin N; Sadowski J; Mysliwiec M
    Transplant Proc; 2010 Dec; 42(10):4251-4. PubMed ID: 21168676
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The prognosis of severe lupus nephritis based on the Modification of Diet in Renal Disease (MDRD) study estimated glomerular filtration rate.
    Patel SB; Korbet SM; Lewis EJ
    Lupus; 2011 Mar; 20(3):256-64. PubMed ID: 21138981
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.